Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

New Line of Laboratory Balances Focuses on Most Often Used Weighing Tasks

By BiotechDaily International staff writers
Posted on 08 May 2014
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Biotech and other life science researchers can increase their productivity by selecting one or more new laboratory balances from an innovative new line.

Sartorius (Gottingen, Germany) recently introduced the new Entris, a balance that focuses on the most commonly used weighing applications and dispenses with costly additional functions.

The line of Entris balances comprised 15 analytical and precision balances that cover a weighing capacity from 60 grams to 8.2 kilograms with a readability of 0.1 milligram to 0.1 gram.

The logical key assignment on the Entris and its clearly structured user interface make daily routine weighing much easier. Most models of the new Entris family are equipped with a monolithic weighing system featuring external adjustment or an internal, motorized adjustment function. This guarantees consistently accurate weighing results, which are displayed on the easy-to-read backlit, high-contrast display.

The Entris system, which can display information in German, English, French, Italian, Spanish, Russian and Polish, is equipped with applications for density determination, animal weighing, counting, conversion, and weighing in percent. The easily removable draft shield and stainless steel parts render the Entris quick and easy to clean.

Related Links:
Sartorius

Channels

Genomics/Proteomics

view channel
Image: Pulsed near infrared light (shown in red) is shone onto a tumor (shown in white) that is encased in blood vessels. The tumor is imaged by photoacoustic tomography via the ultrasound emission (shown in blue) from the gold nanotubes (Photo courtesy of Jing Claussen (iThera Medical, Germany)).

Gold Nanotubes Are Novel Agents for Cancer Diagnosis and Treatment

Cancer researchers have produced a highly defined class of gold nanotubes that are suitable for use in animals as in vivo imaging nanoprobes, photothermal conversion agents, and drug delivery vehicles.... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Lab Technologies

view channel
Image: The FLUOVIEW FVMPE-RS Gantry microscope (Photo courtesy of Olympus).

New Multiphoton Laser Scanning Microscope Configurations Expand Research Potential

Two new configurations of a state-of-the-art multiphoton laser scanning microscope extend the usefulness of the instrument for examining rapidly occurring biological events and for obtaining images from... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.